Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.

Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.

Item
http://www.wikidata.org/entity/Q34168530
Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphomaSensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.Defining the Value of a Comparative Approach to Cancer Drug Development.Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.Epigenetic alterations in osteosarcoma: promising targets.Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin.A pilot phase II study of the efficacy and biosafety of doxorubicin chemotherapy in tumor-bearing equidae.Simultaneous determination of asenapine and valproic acid in human plasma using LC-MS/MS: Application of the method to support pharmacokinetic study.The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma.
P2860

Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.

Item
http://www.wikidata.org/entity/Q34168530
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@ast
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@en
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@nl
type
label
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@ast
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@en
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@nl
prefLabel
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@ast
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@en
Phase I pharmacokinetic and ph ...... dogs with spontaneous cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Phase I pharmacokinetic and ph ...... n dogs with spontaneous cancer
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-10-1238
P407
P433
P478
P50
P577
P698
P932